Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer

Clinical trial NCT04641078 · UNKNOWN

Trial details

NCT number: NCT04641078
Sponsor: University Hospital, Ghent
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostate Cancer Recurrent Prostate Cancer Metastatic Metastatic Cancer Oligometastasis

Start date: 2021-02-12
Primary completion: 2026-02-12
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.